Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis
- 1 July 2004
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 41 (1) , 55-59
- https://doi.org/10.1016/j.jhep.2004.03.016
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA)Clinical Nutrition, 2003
- Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortalityClinical Nutrition, 2003
- Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective studyThe Lancet, 2001
- Asymmetric Dimethylarginine Plasma Concentrations Differ in Patients with End-Stage Renal DiseaseJournal of the American Society of Nephrology, 1999
- Detection of NG, NG-Dimethylarginine Dimethylaminohydrolase in the Nitric Oxide-Generating Systems of Rats Using Monoclonal AntibodyArchives of Biochemistry and Biophysics, 1993
- Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failureThe Lancet, 1992
- Purification and properties of a new enzyme, N, N-dimethylarginine dimethylaminohydrolase, from rat kidneyJournal of Biological Chemistry, 1989
- Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical.Circulation Research, 1987
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973